Kaleido Biosciences, Inc. KLDO OTC

Other OTC • Healthcare • Biotechnology • US • USD

Kaleido Biosciences, Inc. (KLDO) — Analyst outlook / Analyst consensus target is. Based on 7 analyst ratings, the consensus is bullish — 4 Buy, 2 Hold, 1 Sell.

KLDO Analyst Ratings

Buy

Ratings

4 Buy

2 Hold

1 Sell

Based on 7 analysts giving stock ratings to Kaleido Biosciences, Inc. in the past 3 months

Rating breakdown

Buy

4 57%

Hold

2 29%

Sell

1 14%

57%

Buy

4 analysts

29%

Hold

2 analysts

14%

Sell

1 analysts

People Also View

CytomX Therapeutics, Inc.

$4.54

+3.42%

ASMB

Assembly Biosciences, Inc.

$29.44

+0.68%

IKT

Inhibikase Therapeutics, Inc.

Applied Molecular Transport Inc.

$0.26

-3.13%

TPST

Tempest Therapeutics, Inc.

$2.25

+5.14%

Kaleido Biosciences, Inc. KLDO OTC

KLDO Analyst Ratings

People Also View

Get Undervalued Stock Alerts